Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Asthma | R-HSA-444620 | map05310 | capsaicin | 1548943 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | capsaicin | 1548943 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | capsaicin | 1548943 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | capsaicin | 1548943 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | capsaicin | 1548943 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | capsaicin | 1548943 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | capsaicin | 1548943 | drug-path |
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | capsaicin | 1548943 | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | capsaicin | 1548943 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | capsaicin | 1548943 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | capsaicin | 1548943 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | thiethylperazine | 5440 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | thiethylperazine | 5440 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | thiethylperazine | 5440 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | thiethylperazine | 5440 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | thiethylperazine | 5440 | drug-path |
Asthma | R-HSA-444620 | map05310 | thiethylperazine | 5440 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | thiethylperazine | 5440 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | thiethylperazine | 5440 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | thiethylperazine | 5440 | drug-path |